Continued Treatment of Early Nonresponders or Partial Virologic Responders with Bulevirtide Monotherapy in Patients With Chronic Hepatitis Delta Through Week 96 Leads to Improvement in Virologic and Biochemical Responses

Category Primary study
JournalGut and liver
Year 2023
This article has no abstract
Epistemonikos ID: 79f05b90a4532af2b8a157383d49fa0c60e33278
First added on: Apr 29, 2024